Top Buy
| Wertpapier ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 16 | 0 | 2 | 0 | 97,59 € | 116,81 € | 19,69 % |
| AbbVie Inc. | 21 | 0 | 4 | 0 | 148,60 € | 174,43 € | 17,38 % |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | 4,12 € | 34,41 € | 735,26 % |
| Addus Homecare Corp. | 15 | 1 | 4 | 1 | 98,00 € | 103,07 € | 5,17 % |
| Adocia | 1 | 0 | 0 | 0 | 9,01 € | 20,00 € | 121,98 % |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | 1,38 € | 4,66 € | 237,77 % |
| Affimed N.V. | 8 | 6 | 0 | 0 | 0,55 € | 6,54 € | 1083,16 % |
| Agilent Technologies Inc. | 17 | 3 | 1 | 1 | 134,04 € | 134,50 € | 0,34 % |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | 31,00 € | 38,99 € | 25,77 % |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | 1,19 € | 3,60 € | 201,68 % |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | 3,67 € | - | - |
| Align Technology | 15 | 2 | 4 | 0 | 259,60 € | 345,95 € | 33,26 % |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | 141,20 € | 236,30 € | 67,35 % |
| Amedisys Inc. | 14 | 0 | 1 | 0 | 86,00 € | 92,26 € | 7,28 % |
| Amgen Inc. | 25 | 0 | 6 | 0 | 291,85 € | 297,31 € | 1,87 % |
| AnaptysBio Inc | 9 | 1 | 4 | 0 | 24,00 € | 46,24 € | 92,67 % |
| Anika Therapeutics | 5 | 0 | 1 | 0 | 26,40 € | 28,29 € | 7,16 % |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | 39,21 € | 70,00 € | 78,55 % |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | 7,10 € | 11,00 € | 54,93 % |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | 124,00 € | 150,00 € | 20,97 % |
| AstraZeneca plc | 2 | 0 | 1 | 0 | 143,75 € | 165,00 € | 14,78 % |